Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Laryngeal Diseases × Interviews as Topic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 17 Breast Neoplasms 14 Prostatic Neoplasms 13 Colorectal Neoplasms 13 Lung Neoplasms 9 Hematopoietic and Lymphatic System Neoplasm 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Ovarian Neoplasms 4 Multiple Myeloma 4 Malignant Solid Neoplasm 4 Depression 4 Uterine Cervical Neoplasms 3 Lymphoma 3 Hematopoietic and Lymphoid System Neoplasm 3 Hematologic Neoplasms 3 Anxiety Disorders 3 Anatomic Stage I Breast Cancer AJCC v8 3 Advanced Malignant Solid Neoplasm 3 Urinary Bladder Neoplasms 2 Neoplasm Metastasis 2 Mouth Neoplasms 2 Motor Activity 2 Leukemia 2 Laryngeal Neoplasms 2 Head and Neck Carcinoma 2 Gastrointestinal Neoplasms 2 Endometrial Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Carcinoma In Situ 2

Interventions

Cisplatin 10 Cetuximab 8 Radiotherapy 5 pembrolizumab 3 Fluorouracil 3 Docetaxel 3 durvalumab 2 Surveys and Questionnaires 2 Radiotherapy, Intensity-Modulated 2 Pemetrexed 2 Nivolumab 2 N-benzhydryl-5-(2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo(1,2-a)(1,5)diazocine-8-carboxamide 2 Gemcitabine 2 Gefitinib 2 Drug Therapy 2 tremelimumab 1 niraparib 1 monalizumab 1 linrodostat 1 dostarlimab 1 capmatinib 1 X-Rays 1 Vitamin B 12 1 Tirapazamine 1 Tablets 1 Sugars 1 Radiotherapy, Adjuvant 1 Radiosurgery 1 Radiation 1 Proflavine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01647477 2026-03-13

DEREDIA

Centre Oscar Lambret

Phase NA Terminated

Laryngeal Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡